Yuan Liu

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Ben O’Leary, Rosalind Cutts, Yuan Liu et al. · Cancer Discovery · 2018 · 667 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer

Nicholas C. Turner, Yuan Liu, Zhou Zhu et al. · Journal of Clinical Oncology · 2019 · 464 citations · Full text

Medicine, Oncology, Pharmacology +17

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Ben O’Leary, Sarah Hrebien, James P. Morden et al. · Nature Communications · 2018 · 420 citations · Full text

Medicine, Oncology, Pharmacology +17

Correlation of PD-L1 Tumor Expression and Treatment Outcomes in Patients with Renal Cell Carcinoma Receiving Sunitinib or Pazopanib: Results from COMPARZ, a Randomized Controlled Trial

Toni K. Choueiri, David J. Figueroa, André P. Fay et al. · Clinical Cancer Research · 2014 · 248 citations · Full text

Medicine, Immunology, Oncology +17

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study

Massimo Cristofanilli, Hope S. Rugo, Seock‐Ah Im et al. · Clinical Cancer Research · 2022 · 198 citations · Full text

Medicine, Oncology, Pharmacology +14